Legend Biotech to Participate in the 18th Annual Morgan Stanley Virtual Global Healthcare Conference
September 01 2020 - 4:00PM
Business Wire
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a
global clinical-stage biopharmaceutical company engaged in the
discovery and development of novel cell therapies for oncology and
other indications, will participate in the 18th Annual Morgan
Stanley Virtual Global Healthcare Conference on Tuesday, September
15th. Frank Zhang, Chairman and Chief Executive Officer, and Ying
Huang, Chief Financial Officer, will represent the Company in a
session scheduled at 11:00 a.m. (Eastern Time).
This webcast will be available to investors and other interested
parties by accessing the Legend Biotech website at
https://investors.legendbiotech.com.
About Legend Biotech
Legend Biotech is a global clinical-stage biopharmaceutical
company engaged in the discovery and development of novel cell
therapies for oncology and other indications. Our team of over 700
employees across the United States, China and Europe, along with
our differentiated technology, global development, and
manufacturing strategies and expertise, provide us with the strong
potential to discover, develop, and manufacture best-in-class cell
therapies for patients in need.
We are engaged in a strategic collaboration with Janssen
Biotech, Inc. to develop and commercialize our lead product
candidate, ciltacabtagene autoleucel, an investigational
BCMA-targeted CAR-T cell therapy for patients living with multiple
myeloma. This candidate is currently being studied in
registrational clinical trials.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200901006043/en/
Media and Investor Relations: Jessie Yeung, Head of Corporate
Finance and Investor Relations, Legend Biotech
jessie.yeung@legendbiotech.com or investor@legendbiotech.com or
media@legendbiotech.com
Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Jul 2023 to Jul 2024